Medication info
Samsung Rosuvastatin Tablets 5mg (Rosuvastatin Calcium)

Samsung Rosuvastatin Tablets 5mg (Rosuvastatin Calcium)

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›5.2mg / 1 tablet
Manufacturer / importer
Samsung Pharmaceutical Co., Ltd.
Appearance
Yellow round film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201900331 · Approved 2019.01.22 · Insurance code 642307290

Summary

Main use
Improvement of dyslipidemia, reduction of cardiovascular disease risk, and inhibition of atherosclerosis progression
Who uses it
Adults · Children
Adult dosage
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, and most patients are controlled at this dose. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and patient response; it may be increased to a maximum of 20 milligrams daily. 3. Older adults: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Children's dosage
Ages 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Under 10 years of age: Safety and efficacy have not been established.

Ingredients

Manufacturer
Samsung Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of dyslipidemia, reduction of cardiovascular disease risk, and inhibition of atherosclerosis progression

  • Primary hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • primary dysbetalipoproteinemia
  • elevated high-sensitivity C-reactive protein
  • hypertension
  • low HDL cholesterol levels
  • smoking
  • family history of premature coronary heart disease
  • stroke risk
View approved original text

This medication helps when dietary control and exercise do not regulate lipid abnormalities such as primary hypercholesterolemia and mixed hyperlipidemia. It is also used to lower LDL-cholesterol and total cholesterol in patients with homozygous familial hypercholesterolemia or those with hypercholesterolemia to delay the progression of atherosclerosis. It is effective as an adjunct to diet in adolescents aged 10 years and older with familial hypercholesterolemia. Additionally, it assists patients with primary dysbetalipoproteinemia and contributes to reducing the risk of cardiovascular disease, thereby potentially lowering the risk of stroke, myocardial infarction, and arterial revascularization. It is used to improve various types of hyperlipidemia and cardiovascular risks.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, and most patients are controlled at this dose. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and patient response; it may be increased to a maximum of 20 milligrams daily. 3. Older adults: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.

Children's dosage

Ages 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Under 10 years of age: Safety and efficacy have not been established.

Precautions

It is very important not to use this medication in certain patients. For example, those who are allergic to any of the ingredients in this medication should not take it. Moreover, individuals with severely impaired liver function or persistently high liver enzymes of unknown origin should avoid using this medication. Patients with muscle diseases or issues with muscles due to certain autoimmune diseases should also avoid this medication. Patients with severely reduced kidney function, pregnant or nursing women, and women of childbearing potential who are not using adequate contraception should refrain from taking this medication. This medication should be used cautiously in individuals who consume large amounts of alcohol or have a history of liver diseases, and it is advisable to perform liver function tests before and during use. Additionally, if symptoms such as muscle pain or weakness occur, the physician should be informed immediately, and if severe, the medication should be discontinued. Special caution is required for individuals with diminished kidney function, those with thyroid dysfunction or a family history of such, elderly patients, and those who abuse alcohol. This medication may increase blood glucose levels in some patients, so individuals at risk for diabetes should manage their blood sugar meticulously. Furthermore, the effects of this medication can vary due to specific genetic differences; therefore, dose adjustment may be necessary according to the patient's condition. While taking this medication, serious skin rashes or allergic reactions may rarely occur, so if any abnormal skin symptoms arise, the medication should be stopped immediately and a hospital visit should be made. Caution is required when taking this medication with other drugs. In particular, combining it with certain antiviral drugs, immunosuppressants, antifungals, antibiotics, fibrate-class drugs, etc., may lead to increased blood levels of this medication, raising the risk of muscle-related side effects. Therefore, if other medications are being taken, it is essential to inform the doctor or pharmacist, and dose adjustments or monitoring may be necessary. Pregnant or nursing women should not take this medication, and women of childbearing potential should use adequate contraception. Taking this medication during pregnancy can pose risks to the fetus, so it should be discontinued immediately if pregnancy occurs. There is no specific antidote for overdose; therefore, treatment should be symptom-based, and liver function and muscle enzyme tests should be conducted to monitor the condition. Finally, this medication is not known to significantly impair driving or operating machinery, but caution is needed as dizziness may occur.

Side effects

Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, severe muscle weakness, cough, dyspnea, diarrhea, oculobulbar weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, drug-induced lichenoid eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, paresthesia, discomfort in the chest, loss of appetite, abdominal bloating, syncope, generalized pain, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is best to maintain storage temperatures between 1 and 30 degrees Celsius to effectively preserve the medication's efficacy.

Appearance and packaging

Appearance

Yellow round film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.